Abstract:Abstract Background: Angiogenesis is essential for the growth and metastasis of solid tumors, including breast cancer. Although the zinc finger-homeodomain transcription factor ZEB1 is implied as a key regulatory factor in multistep carcinogenesis of breast cancer, its direct role in the regulation of tumor angiogenesis has not been well elucidated. In this report, we extended our study to examine the potential effect of ZEB1 in breast cancer angiogenesis and its molecular mechanism using the in vitro and in vivo models. Materials and Methods: Quantitative RT-PCR, immunoblotting, and ELISA were used to detect ZEB1-induced expression and/or secretion of VEGF in the absence or presence of the indicated signaling pathway inhibitors (the PI3K, NF-κB, and MAPKs pathways) in MDA-MB-231 breast cancer cells. Tube formation assay was performed to detect ZEB1-driven angiogenesis using human umbilical vein endothelial cells (HUVEC). Luciferase and CHIP assays were used to determine the transcriptional activity of the wild-type and mutant VEGF promoters affected by ZEB1. A nude mouse tumor xenograft model was used to examine ZEB1-driven angiogenesis in vivo. The relationship between the expression of ZEB1 and VEGF protein in human breast cancer specimens was assessed by immunohistochemistry. Results: We found that ectopic expression of ZEB1 promotes the expression of VEGF at both the mRNA and the protein levels in MDA-MB-231 cells, which effect is specifically mediated through the p38 and PI3K pathways. The conditioned medium derived from ZEB1-overexpressing MDA-MB-231 cells significantly induces the tube formation of HUVEC compared with that from control-overexpressing cells. Importantly, elevated expression of ZEB1 resulted in an increased angiogenesis in a nude mouse tumor xenograft model. We further moved on to detect whether ZEB1 is a bona-fide transcriptional regulator of VEGF. The results of luciferase and CHIP assays showed that ZEB1 transcriptionally induces the promoter activity of human VEGF by recruiting Sp1 to its biding sites on the VEGF promoter, thus up-regulating VEGF expression in MDA-MB-231 cells. Through the study of breast cancer specimens, we found a strong positive correlation between ZEB1 and VEGF protein expression, further supporting the contribution of ZEB1/VEGF cascade to tumor angiogenesis in breast cancer. Conclusions: Our data demonstrated that ZEB1 up-regulates VEGF expression and thus induces tumor angiogenesis in breast cancer. Thus, inhibition of VEGF expression by down-regulating ZEB1 provides a potential new strategy for overcoming tumor angiogenesis. Citation Format: Qi Tong, Lingjia Liu, Lin Liang, Yang Gao, Shuang Yang. Elevated expression of ZEB1 upregulates VEGF expression and induces tumor angiogenesis in breast cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1599. doi:10.1158/1538-7445.AM2014-1599

Pseudogene CYP4Z2P 3'UTR Promotes Angiogenesis in Breast Cancer.

The 3′UTR of the Pseudogene CYP4Z2P Promotes Tumor Angiogenesis in Breast Cancer by Acting As a Cerna for CYP4Z1

Increased Expression of CYP4Z1 Promotes Tumor Angiogenesis and Growth in Human Breast Cancer.

The competing endogenous RNA network of CYP4Z1 and pseudogene CYP4Z2P exerts an anti-apoptotic function in breast cancer.

ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer

Overexpressed Pseudogenes, DUXAP8 and DUXAP9, Promote Growth of Renal Cell Carcinoma and Serve As Unfavorable Prognostic Biomarkers.

Abstract 1599: Elevated Expression of ZEB1 Upregulates VEGF Expression and Induces Tumor Angiogenesis in Breast Cancer

CYP4Z1 3'UTR Represses Migration of Human Breast Cancer Cells.

High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer.

Pseudogene UBE2MP1 Derived Transcript Enhances in Vitro Cell Proliferation and Apoptosis Resistance of Hepatocellular Carcinoma Cells Through Mir-145-5p/rgs3 Axis.

Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1

Competing Endogenous RNA Networks of CYP4Z1 and Pseudogene CYP4Z2P Confer Tamoxifen Resistance in Breast Cancer

Construction and Analysis of a Novel Pseudogene-Associated Cerna Network to Identify Potential Pseudogene Signature for Diagnosis and Prognosis of Human Triple-Negative Breast Cancer.

Upregulation of estrogen receptor alpha (ERα) expression in transgenic mice expressing human CYP4Z1

Inhibitory Effect of RNA-mediated Knockdown of Zinc Finger Protein 91 Pseudogene on Pancreatic Cancer Cell Growth and Invasion

Downregulated Pseudogene CTNNAP1 Promote Tumor Growth in Human Cancer by Downregulating Its Cognate Gene CTNNA1 Expression

Pseudogene PDIA3P1 Promotes Cell Proliferation, Migration and Invasion, and Suppresses Apoptosis in Hepatocellular Carcinoma by Regulating the P53 Pathway.

Pseudogene SNRPFP1 derived long non-coding RNA facilitates hepatocellular carcinoma progress in vitro by sponging tumor-suppressive miR-126-5p

The Pseudogene Derived Long Noncoding Rna Duxap8 Promotes Gastric Cancer Cell Proliferation And Migration Via Epigenetically Silencing Plekho1 Expression

SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer

RP11-480I12.5-004 Promotes Growth and Tumorigenesis of Breast Cancer by Relieving Mir-29C-3p-mediated AKT3 and CDK6 Degradation.